# Faendrich

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/faendrich

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Total disclosed funding: $4.3M
- Latest round: Series A (May 4, 2023)
- Investors on record: 1

## About

Established in 2020 and based in Shanghai, China, Faendrich is a biotech company that focuses on immune cell research services. In May 2023, it raised CNY 30 million in series A funding from new investor Yunhe Partners. As of 2023, this company's proprietary OPM immune cell cells have completed three international clinical studies on organ transplantation: TAIC-I, TAIC-II and The One Study Mreg trial.

The company is engaged in immune cell research, clinical application research, and cell technology services.

## Funding rounds

- Series A, May 4, 2023, $4.3M — Yunhe Partners

## Investors

- Yunhe Partners (https://capitalatlas.ai/funds/yunhe-partners) — Series A